Abstract:BACKGROUND: Gallbladder carcinoma is a lethal malignant neoplasm with dismal surgical results. Unfortunately, the adjuvant therapies for gallbladder carcinoma such as chemotherapy and radiotherapy are also disappointing. We reported that norcantharidin (NCTD), a demethylated form of cantharidin, which is an active ingredient of the Chinese medicine Mylabris, was used against human gallbladder carcinoma GBC-SD cells. In the present study, we further studied the mechanism underlying the inhibitory effect of NCTD on growth of human gallbladder carcinoma GBC-SD cells in vitro.METHODS: Human gallbladder carcinoma GBC-SD cells were grown in cell culture and divided into a NCTD group and a control group. The inhibitory effect of NCTD on growth of GBC-SD cells was investigated by evaluation of proliferation, cell cycle, apoptosis and morphological changes of the cells. Cell proliferation was assessed by tetrazolium-based colorimetric assay. The induction of cell cycle arrest and apoptosis was measured by flow cytometry. The morphological changes of the cells were observed by light- and electron-microscopy. To elucidate the anticancer mechanism of NCTD, expression of the proliferation-related gene proteins PCNA, Ki-67, cyclin-D-1 and p27 and the apoptosis-related gene proteins Bcl-2, Bax and Survivin were determined by the streptavidin-biotin complex method and RT-PCR.RESULTS: NCTD inhibited the proliferation of GBCSD cells in a dose- and time-dependent manner, with an IC50 of 56.18 mu g/ml at 48 hours. The flow cytometric profiles revealed that NCTD (at the IC50 for 48 hours) significantly increased the proportion of cells in G(2)/M phase and significantly decreased the proportion of cells in S phase, with a significantly increased rate of cell apoptosis. After treatment with the 48-hour IC50 dose of NCTD, cell shrinkage, vacuolar cytoplasm, membrane budding, karyorrhexis, karyolysis, chromosome condensation and chromatin aggregation in some GBCSD cells were observed by light-microscopy; decreased microvilli, Golgiosome atrophy, mitochondrial swelling, nuclear shrinkage, chromosome condensation and typical apoptosis bodies were seen by electron-microscopy, and the morphological changes of apoptosis occurred in GBCSD cells. The expression of PCNA, Ki-67 and Bcl-2 proteins decreased significantly; the Pix or relative levels of PCNA mRNA, cyclin-D-1 mRNA, Bcl-2 mRNA and Survivin mRNA decreased significantly, whereas the Pix or relative levels of p27 mRNA and Bax mRNA increased significantly.CONCLUSIONS: NCTD inhibits the growth of human gallbladder carcinoma GBC-SD cells in vitro. Its anticancer mechanism may correlate with inhibition of cell proliferation, arrest of the cell cycle, blockage of DNA synthesis, influence on cell metabolism, induction of cell apoptosis and influence on expression of the proliferation-related genes PCNA, Ki-67, cyclin-D-1 and p27, and the apoptosis-related genes Bcl-2, Bax and Survivin in human gallbladder carcinoma GBC-SD cells.

Norcantharidin Triggers Cell Death and Dna Damage Through S-Phase Arrest and Ros-Modulated Apoptotic Pathways in Tsgh 8301 Human Urinary Bladder Carcinoma Cells

Cantharidin Inhibits Anti-Apoptotic Bcl-2 Family Proteins and Induces Apoptosis in Human Osteosarcoma Cell Lines MG-63 and MNNG/HOS Via Mitochondria-Dependent Pathway.

Norcantharidin Blocks Wnt/β-catenin Signaling Via Promoter Demethylation of WIF-1 in Glioma.

Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.

Cantharidin Alters the Expression of Genes Associated with the NKG2D-associated Immune Response in TSGH-8301 Human Bladder Carcinoma Cells.

Norcantharidin (NCTD) induces mitochondria mediated apoptosis in human HepG2 cells

Cantharidin Induces DNA Damage and Inhibits DNA Repair-Associated Protein Expressions in TSGH8301 Human Bladder Cancer Cell.

The Anti-Proliferative Effects of Norcantharidin on Human HepG2 Cells in Cell Culture

Effect of Norcantharidin on Inducing Apoptosis of Human Cutaneous Squamous Cell Carcinoma A431 Cells

Cantharidin Induces Apoptosis in Human Bladder Cancer TSGH 8301 Cells Through Mitochondria-Dependent Signal Pathways

Inhibitory Effect of Norcantharidin on the Growth of Human Gallbladder Carcinoma Gbc-Sd Cells in Vitro

Involvement of Mitochondrial Pathway in NCTD-induced Cytotoxicity in Human Hepg2 Cells.

Norcantharidin Triggers Apoptotic Cell Death in Non-Small Cell Lung Cancer Via a Mitophagy-Mediated Autophagy Pathway

Norcantharidin Inhibits Growth of Human Gallbladder Carcinoma Xenografted Tumors in Nude Mice by Inducing Apoptosis and Blocking the Cell Cycle in Vivo.

Influence of norcantharidin on growth of GBC-SD cell lines with human gallbladder carcinoma

Norcantharidin inhibits the malignant progression of cervical cancer by inducing endoplasmic reticulum stress

Norcantharidin Induced Du145 Cell Apoptosis Through Ros-Mediated Mitochondrial Dysfunction and Energy Depletion

Study on the antineoplastic effect of cantharidin and norcantharidin for carcinoma cell of bladder

Cantharidin Induces G2/M Phase Arrest and Apoptosis in Human Colorectal Cancer Colo 205 Cells Through Inhibition of CDK1 Activity and Caspase-Dependent Signaling Pathways.

[Molecular Mechanism of Norcantharidin Inducing Apoptosis in Liver Cancer Cells].

Determination of Norcantharidin-Associated Proteins by Comparative Proteomic Analysis in Bgc-823 Cells